#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	15384	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2070	737.5	0	.	n	.	0	C1450T	SNP	1450	1450	C	1712	1712	T	796	T,C	738,2	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	15384	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2070	737.5	1	SNP	n	C1184T	0	.	.	1184	1184	C	1446	1446	C	889	C	842	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27916	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3617	769.8	0	.	n	.	0	G1337A	SNP	1337	1337	G	1703	1703	A	927	A,G	881,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27916	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3617	769.8	0	.	n	.	0	T1971C	SNP	1971	1971	T	2337	2337	C	951	C	891	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27916	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3617	769.8	1	SNP	n	A2045G	0	.	.	2045	2045	A	2411	2411	A	946	A	912	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27916	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3617	769.8	1	SNP	n	C2597T	0	.	.	2597	2597	C	2963	2963	C	846	C,T	808,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	2298	folP	855	855	100.0	folP.l15.c4.ctg.1	1545	147.8	1	SNP	p	R229S	1	.	.	685	687	AGC	1051	1053	AGC	200;201;199	A;G;C	196;197;195	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6084	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3257	185.6	1	SNP	p	S91F	1	.	.	271	273	TTC	505	507	TTC	222;224;223	T;T;C	207;209;205	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6084	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3257	185.6	1	SNP	p	D95G	1	.	.	283	285	GGC	517	519	GGC	218;216;218	G;G;C	202;202;203	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6084	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3257	185.6	1	SNP	p	G95N	0	.	.	283	285	GGC	517	519	GGC	218;216;218	G;G;C	202;202;203	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	27	1862	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1281	144.5	1	SNP	p	G45D	0	.	.	133	135	GGC	470	472	GGC	237;237;235	G;G;C	223;219;218	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	1004	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1021	98.0	0	.	n	.	0	A197.	DEL	197	197	A	618	618	A	239	A	231	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	5634	parC	2304	2304	99.87	parC.l15.c30.ctg.1	2982	187.9	0	.	p	.	0	I384V	NONSYN	1150	1152	ATC	1606	1608	GTC	248;249;250	G;T;C	231;228;231	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	5634	parC	2304	2304	99.87	parC.l15.c30.ctg.1	2982	187.9	1	SNP	p	D86N	0	.	.	256	258	GAC	712	714	GAC	237;237;240	G;A;C	217;211;225	parC.WHO_V_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	5634	parC	2304	2304	99.87	parC.l15.c30.ctg.1	2982	187.9	1	SNP	p	R87I	0	.	.	259	261	CGT	715	717	CGT	240;235;234	C,A;G;T	224,1;220;216	parC.WHO_V_00204c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	5634	parC	2304	2304	99.87	parC.l15.c30.ctg.1	2982	187.9	1	SNP	p	R87W	0	.	.	259	261	CGT	715	717	CGT	240;235;234	C,A;G;T	224,1;220;216	parC.WHO_V_00204c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	5634	parC	2304	2304	99.87	parC.l15.c30.ctg.1	2982	187.9	1	SNP	p	S87R	1	.	.	259	261	CGT	715	717	CGT	240;235;234	C,A;G;T	224,1;220;216	parC.WHO_V_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	5634	parC	2304	2304	99.87	parC.l15.c30.ctg.1	2982	187.9	1	SNP	p	S88P	0	.	.	262	264	TCC	718	720	TCC	235;233;235	T;C;C	214;216;220	parC.WHO_V_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	4606	parE	1986	1986	99.95	parE.l15.c4.ctg.1	2648	173.4	0	.	p	.	0	R340C	NONSYN	1018	1020	CGC	1332	1334	TGC	199;195;196	T,C;G;C	178,2;180;183	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	4606	parE	1986	1986	99.95	parE.l15.c4.ctg.1	2648	173.4	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1542	1544	GGC	237;238;234	G;G;C	226;223;221	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.12.001	penA.12.001	1	1	27	4364	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2392	182.0	1	SNP	p	A311V	0	.	.	931	933	GCA	1248	1250	GCA	251;254;255	G;C;A	235;240;244	penA.12.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4364	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2392	182.0	1	SNP	p	I312M	0	.	.	934	936	ATC	1251	1253	ATC	255;257;259	A;T;C	245;244;246	penA.12.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4364	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2392	182.0	1	SNP	p	V316P	0	.	.	946	948	GTG	1263	1265	GTG	258;256;258	G;T;G	246;244;245	penA.12.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4364	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2392	182.0	1	SNP	p	V316T	0	.	.	946	948	GTG	1263	1265	GTG	258;256;258	G;T;G	246;244;245	penA.12.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4364	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2392	182.0	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1767	1769	ACC	209;210;212	A;C;C	197;203;205	penA.12.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4364	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2392	182.0	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1821	1823	GCG	190;188;192	G;C,G;G	149;137,1;147	penA.12.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4364	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2392	182.0	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1821	1823	GCG	190;188;192	G;C,G;G	149;137,1;147	penA.12.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4364	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2392	182.0	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1944	1946	GGC	200;200;201	G;G;C	192;192;192	penA.12.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4364	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2392	182.0	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1953	1955	GGC	194;191;192	G;G;C	183;179;180	penA.12.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4364	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2392	182.0	1	SNP	p	P552S	1	.	.	1654	1656	TCG	1971	1973	TCG	185;186;184	T,G;C;G	121,10;144;153	penA.12.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6202	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3168	195.1	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1631	1633	CCG	223;222;222	C;C,T;G	197;202,1;199	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2616	porA	1146	1146	99.56	porA.l15.c4.ctg.1	1813	143.6	0	.	p	.	0	M83fs	FSHIFT	247	247	A	531	531	C	196	C	182	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3000	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1536	194.1	0	.	p	.	0	N38E	NONSYN	112	114	AAT	404	406	GAA	248;250;251	G;A;A	229;232;232	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3000	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1536	194.1	0	.	p	.	0	N134D	NONSYN	400	402	AAT	692	694	GAT	242;240;243	G,A;A;T	228,1;228;231	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3000	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1536	194.1	0	.	p	.	0	P175S	NONSYN	523	525	CCA	815	817	TCA	267;270;271	T;C,G;A	248;249,1;252	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3000	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1536	194.1	0	.	p	.	0	A218V	NONSYN	652	654	GCC	944	946	GTC	245;243;239	G;T;C	233;235;232	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3000	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1536	194.1	0	.	p	.	0	R258H	NONSYN	772	774	CGT	1064	1066	CAT	272;272;271	C;A;T	253;253;253	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3000	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1536	194.1	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1274	1276	GCA	210;210;212	G;C;A	198;200;200	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3000	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1536	194.1	1	SNP	p	G120K	1	.	.	358	360	AAG	650	652	AAG	253;253;247	A;A;G	240;239;238	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3000	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1536	194.1	1	SNP	p	A121D	1	.	.	361	363	GAC	653	655	GAC	244;243;244	G,A;A;C,A	230,1;226;233,1	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3000	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1536	194.1	1	SNP	p	D121N	0	.	.	361	363	GAC	653	655	GAC	244;243;244	G,A;A;C,A	230,1;226;233,1	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10790	rpoB	4179	4179	100.0	rpoB.l6.c4.ctg.1	5083	211.8	1	SNP	p	H553N	1	.	.	1657	1659	AAT	2144	2146	AAT	264;261;258	A;A;T	246;244;242	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1210	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1133	106.1	1	SNP	p	V57M	1	.	.	169	171	ATG	506	508	ATG	267;267;266	A;T;G	248;245;246	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
